30 Participants Needed

Exercise Training Modalities for Cardiovascular Disease

AS
SH
Overseen BySean Heffron, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests various aerobic exercise methods to help reduce heart disease risk. It compares in-person workouts with remote exercise training options, such as app-based and live-streamed sessions, to determine the most effective and user-friendly approach. The study welcomes participants who haven't met heart health activity guidelines and have risk factors like high blood pressure, high cholesterol, Type 2 diabetes, smoking, obesity, or a family history of early heart disease. Participants will engage in one exercise method for 12 weeks and provide feedback on its effectiveness and ease of use. As an unphased trial, this study offers a unique opportunity to explore innovative exercise methods that could enhance heart health and overall well-being.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially since the trial includes people using anti-hypertensive and diabetes medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that remote exercise programs are generally safe for individuals at risk of heart disease. These programs include online and app-based workouts. Studies have found that participants in home-based heart rehab programs express high satisfaction and adhere well to their exercise plans.

In the Asynchronous Remote Aerobic Exercise Intervention, research found that remote exercises are safe and effective. Participants managed their workouts with occasional feedback from trainers.

For the Remote MyZone Aerobic Exercise Intervention, studies indicate that heart rate-monitored exercises are safe when properly supervised. This method uses an app to provide real-time feedback and motivation, helping participants safely adjust their workout intensity.

The Remote Synchronous Aerobic Exercise Intervention, involving live-streamed sessions, has also proven safe. Participants in remote exercise programs reported better access to health care and found them easy to use.

Overall, these remote training methods are not only safe but also user-friendly, making them a promising option for those seeking to improve heart health without visiting a gym.12345

Why are researchers excited about this trial?

Researchers are excited about these exercise training modalities for cardiovascular disease because they offer innovative, flexible ways to engage patients. Traditional cardiac rehab often requires in-person sessions, but these new methods include remote options that provide real-time feedback and allow patients to exercise at home. The Remote MyZone Aerobic Exercise Intervention, for example, uses a heart rate monitor and app for instant intensity guidance and motivation through social features. Meanwhile, the Remote Synchronous Aerobic Exercise Intervention offers live-streamed sessions with immediate trainer feedback, making it feel like a live class from the comfort of your home. These advancements aim to make cardiac rehabilitation more accessible, convenient, and engaging for patients.

What evidence suggests that this trial's exercise training modalities could be effective for cardiovascular disease?

Studies have shown that exercise-based cardiac rehabilitation (CR) can reduce the risk of dying from heart disease. This trial compares different exercise training modalities for cardiovascular disease. Research indicates that remote exercise programs, such as those using apps and heart rate monitors, are as effective as in-person sessions. In this trial, participants in the Remote MyZone Aerobic Exercise Intervention (RMZAEI) will use the Myzone program, which offers personalized feedback and social features to motivate individuals, leading to better exercise habits and fitness levels. Participants in the Remote Synchronous Aerobic Exercise Intervention (RSAEI) will join live virtual sessions with real-time guidance, which have been shown to improve exercise capacity. These programs are safe for people with heart disease and can enhance heart health when used regularly.12346

Who Is on the Research Team?

SP

Sean P. Heffron, MD

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for individuals at risk for Cardiovascular Disease who are not currently meeting the American Heart Association guidelines for physical activity. Participants will be randomly assigned to one of four exercise training modalities and must undergo Cardiopulmonary Exercise Testing before and after the 12-week program.

Inclusion Criteria

Not meeting AHA physical activity guidelines for at least 3 months prior to screening
I am older than 45 years.
I am at risk for heart disease due to factors like high blood pressure, high cholesterol, diabetes, smoking, obesity, or family history.

Exclusion Criteria

Presence of any serious medical conditions that would not allow safe participation in exercise according to ACSM and AHA guidelines
Pregnant or anticipating pregnancy
Presence of any biopsychosocial factors that the principal investigator deems as having significant potential to interfere with effective study participation
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo 12 weeks of aerobic training using one of four modalities: In-Person Supervised, Asynchronous Remote, Remote MyZone, or Remote Synchronous.

12 weeks
Regular virtual or in-person sessions depending on the modality

Follow-up

Participants are monitored for changes in physical activity, cardiovascular fitness, and CVD risk, and respond to questions regarding acceptability of the interventions.

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Remote Exercise Training Modalities
Trial Overview The study tests the acceptability and effectiveness of different aerobic training methods: a smart-device app (MyZone), asynchronous virtual classes, synchronous virtual classes, in-person sessions, using Myzone heart rate monitors or Map My Fitness app over a period of 12 weeks.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Remote Synchronous Aerobic Exercise Intervention (RSAEI)Experimental Treatment2 Interventions
Group II: Remote MyZone Aerobic Exercise Intervention (RMZAEI)Experimental Treatment2 Interventions
Group III: Asynchronous Remote Aerobic Exercise Intervention (RASAEI)Experimental Treatment2 Interventions
Group IV: In-Person Supervised Aerobic Exercise Intervention (IPSAEI)Active Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

Published Research Related to This Trial

Cardiac telerehabilitation significantly improves long-term cardiopulmonary fitness in patients with coronary artery disease (CAD), showing a mean difference of 1.61 in peak oxygen uptake compared to traditional center-based rehabilitation.
Patients participating in cardiac telerehabilitation also experience an improvement in quality of life, with a mean difference of 0.92, while maintaining a high completion rate of 80% and a low incidence of adverse events.
Longer-Term Effects of Cardiac Telerehabilitation on Patients With Coronary Artery Disease: Systematic Review and Meta-Analysis.Zhong, W., Liu, R., Cheng, H., et al.[2023]
A smartphone-guided training system (GEX) for cardiac rehabilitation (CR) was found to be feasible and safe, with no training-related complications reported during the study involving 118 patients with coronary artery disease.
Patients using the GEX system showed a significant improvement in exercise capacity (peak VO2) compared to those receiving conventional CR, indicating that remote monitoring can enhance rehabilitation outcomes.
Internet-based training of coronary artery patients: the Heart Cycle Trial.Skobel, E., Knackstedt, C., Martinez-Romero, A., et al.[2022]
Cardiac rehabilitation (CR) programs significantly reduce future cardiac events and mortality, but only about 10% of eligible patients participate due to geographical barriers.
The development of virtual CR programs, utilizing technologies like the Internet and smartphones, shows promise in improving patient access and has demonstrated positive effects on clinical outcomes in small randomized trials.
The Delivery of Cardiac Rehabilitation Using Communications Technologies: The "Virtual" Cardiac Rehabilitation Program.Lear, SA.[2019]

Citations

Outcomes of a Remote Cardiac Rehabilitation Program for ...This study aims to assess the feasibility and effectiveness of a 12-week asynchronous remotely supervised exercise and patient education program
A Pilot Feasibility and Acceptability Study of Remote ...The study aims to 1) Assess the effect of several approaches to remote aerobic training on measures of physical activity, cardiovascular fitness and CVD risk, ...
Long-Term Outcomes of Digital Cardiac RehabilitationAnderson et al reported that exercise-based CR reduces the risk of mortality from CVD compared with non-exercise control groups. Additionally, they noted a ...
The Effectiveness of Remote Exercise Rehabilitation ...This study aims to investigate the impact of remote exercise rehabilitation on time investment and related cognitive levels in homebound patients with CHD.
Exercise Training Modalities for Cardiovascular DiseaseResearch shows that exercise training, including remote and virtual programs, is generally safe for people with cardiovascular disease when properly monitored.
Safety, feasibility and effectiveness of the remotely delivered ...The present study found that a novel and entirely remotely delivered physical activity intervention is safe, feasible and effective in medically ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security